According to the latest report by IMARC Group, titled, “Acne Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028“, The global acne drugs market size reached US$ 6.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 9.2 Billion by 2028, exhibiting a growth rate (CAGR) of 5.3% during 2023-2028.
Acne refers to a common skin condition that occurs when hair follicles become plugged with oil and dead skin cells and cause whiteheads, blackheads, lumps, and pimples. It comprises non-inflammatory and inflammatory acne that can affect permanent scars on the skin. It can also be caused by menstruation, improper diet, emotional stress, hot and humid climate, and allergic cosmetics. Acne can be cured by various prescriptions and consuming over-the-counter (OTC) drugs, such as retinoids, antibiotics, salicylic acid, benzoyl peroxide, and oral contraceptives.
Request Free Sample Report (Exclusive Offer on this report): https://www.imarcgroup.com/acne-drugs-market/requestsample
Acne Drugs Market Trends and Drivers:
Presently, the rising prevalence of skin conditions among teenagers and adults around the world represents one of the key factors strengthening the market growth. Besides this, the growing awareness among consumers about numerous acne products and treatment options is offering a positive market outlook. Apart from this, the increasing development of effective acne drugs with minimal side effects and high potential is bolstering the growth of the market. Moreover, the wide availability of acne drugs through various distribution channels, such as pharmacies, drug, and online stores, is offering a lucrative growth opportunity to industry investors. Furthermore, key manufacturers are introducing isotretinoin capsules for patients suffering from recalcitrant nodular acne, which is propelling the growth of the market.
Acne Drugs Market Report 2023-2028 Competitive Analysis and Segmentation:
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
- Allergan Plc
- Bausch Health Companies Inc.
- Bayer Aktiengesellschaft
- Cipher Pharmaceuticals Inc.
- Galderma Holding SA
- Johnson & Johnson
- Pfizer Inc.
- Reckitt Benckiser Group Plc
- Skinvisible Pharmaceuticals Inc.
- Sun Pharmaceutical Industries Limited
- Teva Pharmaceutical Industries Ltd.
The report has segmented the market based on acne type, drug class, drug type and route of administration.
Breakup by Acne Type:
- Comedonal
- Inflammatory
- Cystic
- Postsurgical/Wound
Breakup by Drug Class:
- Retinoids
- Antibiotics
- Hormonal Agents
- Combination Drugs
- Others
Breakup by Drug Type:
- OTC Drugs
- Prescription Drugs
Breakup by Route of Administration:
- Topical
- Oral
- Injectable
Breakup by Region:
- North America
- Asia-Pacific
- Europe
- Latin America
- Middle East and Africa
Ask Analyst for Customization and Browse full report with TOC & List of Figure: https://www.imarcgroup.com/acne-drugs-market
Key highlights of the report:
- Market Performance (2017-2022)
- Market Outlook (2023-2028)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact us:
IMARC Group
Email: sales@imarcgroup.com
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA
Website: https://www.imarcgroup.com/
Follow us on Twitter: @imarcglobal
Linkedin: https://www.linkedin.com/company/imarc-group
